67 /100
HIGH RISK
Score updated Jul 14, 2026

IBO — Impact BioMedical Inc. Dilution Risk Tracker

Track IBO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IBO — Get alerts when the score changes →

As of July 14, 2026, Impact BioMedical Inc. (IBO) has a DilutionWatch DilutionScore of 67/100, rated HIGH dilution risk. Impact BioMedical Inc. has a market capitalization of $56.07M, 107.82M shares outstanding, 22 institutional holders tracked. Key dilution vectors include approximately 0 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
75
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
53%
🔄 Reverse Split 70%
• 50-day avg $0.62 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 0.1 months cash remaining
📉 Score Deterioration 10%
• Score in HIGH risk zone (67/100)
🔔 Track IBO — Get forecast alerts →

💹 Market Data

Market Cap$56.07M
Shares Outstanding107.82M
Float11.44M
Cash$20.0K
Debt$11.90M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 209.1% shares (2026Q1 vs prior)
22 institutional holders · 4.45M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.42M shares
#2 GEODE CAPITAL MANAGEMENT, LLC 1.19M shares
#3 STATE STREET CORP 607.9K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest556.5K
Days to Cover7.4
% of Float4.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for IBO Shareholders

Impact BioMedical Inc. (IBO) has a DilutionScore of 67/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: IBO has approximately 0 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for IBO in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for IBO alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track IBO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IBO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

AGMH ALLR AMSS APC APRE

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for IBO
📊 IBO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IBO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.